Krystal Biotech, Inc. (KRYS)
341.78
-4.80
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
341.78
0.00 (0.00%)
After-Hours: 19:58
Krystal Biotech Shareholders Equity (Quarterly) : 1.359B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.359B |
| March 31, 2026 | 1.277B |
| December 31, 2025 | 1.220B |
| September 30, 2025 | 1.138B |
| June 30, 2025 | 1.041B |
| March 31, 2025 | 984.67M |
| December 31, 2024 | 946.38M |
| September 30, 2024 | 885.85M |
| June 30, 2024 | 838.89M |
| March 31, 2024 | 799.24M |
| December 31, 2023 | 778.64M |
| September 30, 2023 | 755.95M |
| June 30, 2023 | 653.11M |
| March 31, 2023 | 489.57M |
| December 31, 2022 | 522.23M |
| September 30, 2022 | 540.77M |
| June 30, 2022 | 559.18M |
| March 31, 2022 | 548.55M |
| December 31, 2021 | 593.58M |
| September 30, 2021 | 408.24M |
| Date | Value |
|---|---|
| June 30, 2021 | 418.54M |
| March 31, 2021 | 430.65M |
| December 31, 2020 | 292.08M |
| September 30, 2020 | 301.72M |
| June 30, 2020 | 309.70M |
| March 31, 2020 | 198.37M |
| December 31, 2019 | 202.91M |
| September 30, 2019 | 207.65M |
| June 30, 2019 | 198.29M |
| March 31, 2019 | 109.49M |
| December 31, 2018 | 113.23M |
| September 30, 2018 | 52.29M |
| June 30, 2018 | 45.27M |
| March 31, 2018 | 47.40M |
| December 31, 2017 | 49.47M |
| September 30, 2017 | 50.20M |
| June 30, 2017 | -0.829M |
| March 31, 2017 | -0.114M |
| December 31, 2016 | 0.289M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 12.17M |
| TG Therapeutics, Inc. | 604.08M |
| Tenaya Therapeutics, Inc. | 69.41M |
| Cytokinetics, Inc. | -173.49M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.501B |
| Total Liabilities (Quarterly) | 141.52M |
| Debt to Equity Ratio | 0.0065 |
| Current Ratio | 8.318 |
| Net Debt Paydown Yield | 0.00% |